US20040105902A1 - Compositions and methods for treating prostate cancer - Google Patents

Compositions and methods for treating prostate cancer Download PDF

Info

Publication number
US20040105902A1
US20040105902A1 US10/307,651 US30765102A US2004105902A1 US 20040105902 A1 US20040105902 A1 US 20040105902A1 US 30765102 A US30765102 A US 30765102A US 2004105902 A1 US2004105902 A1 US 2004105902A1
Authority
US
United States
Prior art keywords
radix
rhizoma
fructus
herba
semen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/307,651
Inventor
Jiafang Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/307,651 priority Critical patent/US20040105902A1/en
Priority to PCT/US2003/038114 priority patent/WO2004050026A2/en
Priority to AU2003293194A priority patent/AU2003293194A1/en
Publication of US20040105902A1 publication Critical patent/US20040105902A1/en
Priority to US11/082,987 priority patent/US7300676B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Definitions

  • the present invention relates to improvements in animal health, especially the health of humans, particularly male humans.
  • the medical systems of an animal especially the digestive system, blood circulation system, urinary system, and liver and kidney system, and overall health may be improved by the present invention.
  • the prostate is a male reproductive gland, which is located below the bladder and adjacent to the rectum.
  • a normal sized prostate gland is about the size of a walnut and encircles at least part of the urethra (which is the tube used to empty the bladder of urine). Fluid is produced by the prostate gland which then becomes part of the semen.
  • BPH benign hyperplasia
  • Prostate cancer is a disease manifested in malignant (cancerous) cells in the prostate tissues. This disease is found mainly in older men. Symptoms include, but are not limited to, weak flow of urine, interrupted flow of urine, frequent urination (especially at night), difficulty urinating, pain or burning during urination, blood in urine, blood in semen, pain in the back, hips or pelvis, and painful ejaculation.
  • PSA test a lab test that measures the prostate-specific antigen (hereinafter “PSA”) levels in a blood sample
  • transrectal ultrasound a lab test that measures the prostate-specific antigen
  • PSA is a substance produced by the prostate gland and is often found in increased amount in the blood of prostate cancer victims. Other reasons for elevated PSA levels include infection of the prostate, inflammation of the prostate, or BPH.
  • PSA levels of less than about 2 ng/ml are associated with a very low risk of cancer.
  • PSA levels from about 4 to about 10 ng/ml are borderline. It is estimated that about 20% to about 30% of men with PSA levels in this range have prostate cancer. About 40% to about 60% of men with PSA levels greater than about 10 ng/ml, are estimated to have prostate cancer.
  • Healthcare professionals usually follow up the PSA test with transrectal ultrasounds and/or biopsies.
  • TCM Traditional Chinese Medicine
  • TCM Other forms of medicine, other than TCM, utilize PSA levels to gauge levels of cancerous activity.
  • TCM is only now beginning to examine liver and kidney system (including, but not limited to kidney, liver and gallbladder) and urinary system (including but not limited to urinary and reproductive organs) problems. These problems may be assessed through, but are not limited to, checking acupuncture points, pulse readings and physical examination of the tongue. Additionally, physical symptoms include but are not limited to swollen prostate and pain or burning during urination.
  • Prostate and urinary related problems such as, but not limited to, swollen or enlarged prostate, high PSA, pain and/or burning sensations during urination and prostate cancer may be prevented and/or treated by the present invention.
  • the present invention may be used to treat and/or prevent prostate and urinary problems in animals, preferably human, most preferably human males, including but not limited to prostate cancer, especially the early stages of prostate cancer.
  • a composition comprising one or more digestive system improvement herbs, one or more blood circulation improvement (including but not limited to maintaining about normal blood temperature, or maintaining about normal and about constant blood flow) herbs, one or more urinary system improvement herbs, one or more liver and kidney system improvement herbs, or combinations thereof is one embodiment of the invention.
  • Herbs are defined to include, but are not limited to, herbs, herbal extracts, any part of an herb, chemicals, chemical extracts, medicine and medicinal substances.
  • an embodiment of the invention is a method of preventing and/or treating prostate problems (including but not limited to, enlarged prostate, prostate cancer, and elevated (benign, precancerous or malignant) levels of PSA, pain during urination, and burning during urination) by administering a composition comprising one or more digestive system improvement herbs, one or more blood circulation improvement herbs, one or more urinary system improvement herbs, one or more liver and kidney system improvement herbs, or combinations thereof.
  • prostate problems including but not limited to, enlarged prostate, prostate cancer, and elevated (benign, precancerous or malignant) levels of PSA, pain during urination, and burning during urination
  • a composition comprising one or more digestive system improvement herbs, one or more blood circulation improvement herbs, one or more urinary system improvement herbs, one or more liver and kidney system improvement herbs, or combinations thereof.
  • the digestive system performs the functions of digesting foods, absorbing nutrients, delivering nutrients and fluid to the rest of the body, and helps to make blood. Without being limited or held to the mechanisms, it is believed that the normal functioning of digestive system provides a foundation for a healthy body and a strong immune system.
  • Another embodiment of the invention is a method of improving performance of the digestive system of an animal by administering a composition
  • a composition comprising astragali seu hedysari radix, codonopsis pilosulae radix, atractylodes rhizoma, poria cocos, raphni semen, xingiberis siccatun rhizoma, atractylodis lanceae rhizoma, amomi fructus, agastache rugosa herba, artemisiae capillaris herba, coicis semen, dianthi herba, evodiae fructus, alpiniae officinarum rhizoma, foeniculi fructus, saussureae radix, cyperi rhizoma, crataegi fructus, massa medicata fermentata, endothelium corneum gigeriae galli, hordei germinat
  • Another embodiment of the invention is a method of improving blood circulation of an animal by administering a composition comprising rehmanniae radix, gardeniae fructus, moutan radicis cortex, glehniae radix, adenophorae radix, asparigi radix, ophiopogonis radix, dendrobii herba, ecliptae herba, carapax et plastrum testudinis, plastrum testudinis, agrimoniae herba, callicar pa pedunculata, cephalanoploris herba, cacumen biota, sophorae flos, sanguisorbae radix, rubiae radix, typhae pollen, loti rhizomatis nodus, notoginseng radix, tribuli fructus, haematitum, bupleuri radix, lycii radicis cortex, pa
  • Another embodiment of the invention is a method of maintaining blood temperature of an animal by administering a composition comprising rehmanniae radix, gardeniae fructus, moutan radicis cortex, glehniae radix, adenophorae radix, asparigi radix, ophiopogonis radix, dendrobii herba, ecliptae herba, carapax et plastrum testudinis, plastrum testudinis, agrimoniae herba, callicar pa pedunculata, cephalanoploris herba, cacumen biota, sophorae flos, sanguisorbae radix, rubiae radix, typhae pollen, loti rhizomatis nodus, notoginseng radix, tribuli fructus, haematitum, bupleuri radix, lycii radicis cortex, pa
  • the urinary system includes the bladder and urinary track, and in males, the prostate gland.
  • Another embodiment of the invention is a method of improving the function of the urinary system of an animal by administering a composition comprising one or more of the group consisting of gelchoma herba, dioscoreae hypoglauca rhizoma, lygodii spora, ostreae testa, taraxaci herba, lopatheri herba, gypsum fibrosum, lonicerae flos, frosythiae fructus, violae herba, houttuyniae herba, thlaspi herba, smilacis glabrae rhizoma, portulacae herba, phaseolus radiatus, phizoma paridis, hedyotis diffasae herba, phellodendri cortex, gentianae radix, sophorae radix, scute
  • the liver and kidney system performs the functions of blood storage and blood purification, blood supply regulation, partially regulates blood circulation, regulates the functions of the urinary system, may promote body growth, consolidates the quality of bone and partially regulates the discharge of body fluid.
  • Another embodiment of the invention is a method of improving liver and kidney system of an animal by administering a composition comprising one or more of the group consisting of achyranthis radix, morindae radix, rehmanniae radix, schizandrae fructus, comi fructus, euryalis semen, mantidis otheca, loranthi ramulus, plastrum testudinis, ligustri lucidi fructus, lycii fructus, euphora longan, mori fructus, asini gelatinum, paeoniae alba radix, angelicae radix, polygoni multiflori radix, eucommiae cortex, cibotii rhizoma, dipsaci radix, cnidii monnieri fructus, cordyceps senesis, ko gecko, cuscutae semen, cistanchis
  • the present invention utilizes herbs to improve the function of the digestive system.
  • This improvement of the digestive system may enhance the immune system and bolster the natural defense of the animal body, preferably the human body, more preferably the male human body.
  • this natural defense appears to be crucial in terms of treating many disorders and diseases, including but not limited to prostate cancer, prostate problems, urinary problems, immune system problems, cardiovascular problems, pulmonary problems, reproductive problems, neurological problems, endocrine and metabolic problems, gastrointestinal problems, hepatic and biliary problems, musculaskeleta and connective tissue problems, dermatological problems, and hematological and oncological problems.
  • the immune system includes the natural defense system of the animal, which wards off disease, infections, viruses, and other illnesses and disorders.
  • the present invention improves blood circulation, which may help keep blood temperature about normal.
  • Stable, normal blood temperature for an animal may help reduce infection of the prostate and improve the urination function (including but not limited to by regular frequency of urination, eliminating pain and burning during urination, and normalizing flow of urine).
  • Stable, normal blood temperature for an animal may help reduce infection of various organs, including but not limited to the liver, kidneys, and immune system.
  • the present invention has many embodiments, including but not limited to, mixing the herbs and boiling the mixture to yield a tea, pulverizing the herbs to a powder (preferably a fine powder) and mixing it with water for ingestion, abstracting herbal extracts using chemical solvents which are conventionally known, and preferably pulverizing herbs, encapsulating them and ingesting the capsules orally.
  • the dosage for an animal may vary according to its health and condition.
  • An average dose is about 20 to about 90 grams, preferably about 20 to about 23 grams or about 80 to about 90 grams, most preferably about 40 to about 45 grams of the mixture.
  • This dose is preferably taken about one to about three times a day, preferably about two to about three times a day.
  • the dose is taken for preferably about 180 to about 730 days.
  • the digestive system improvement herbs include but are not limited to the following: Chinese Pin Yin (Chinese Name) Latin Huang Qi (Sheng) Astraali seu Hedysari Radix Dang Shen Codonopsis Pilosulae Radix Bai Zhu Atractylodes Rhizoma Fu Ling Poria Cocos Lai Fu Zi Raphni Semen Gan Jiang Zingiberis Siccatun Rhizoma Cang Zhu Atractylodis Lanceae Rhizoma Sha Ren Amomi Fructus Huo Xiang Agastache Rugosa Herba Yin Chen Artemisiae Capillaris Herba Yi Ren Coicis Semen Qu Mai Dianthi Herba Wu Zhu Yu Evodiae Fructus Gao Liang Jiang Alpiniae Officinarum Rhizoma Xiao Hui Xiang Foeniculi Fructus Mu Xiang Saussureae Radix Xi
  • the blood circulation improvement herbs include but are not limited to the following: Chinese Pin Yin Latin Sheng Di Huang Rehmanniae Radix Zhi Zi Gardeniae Fructus Mu Dan Pi Moutan Radicis Cortex Sha Shen (Bei) Glehniae Radix Sha Shen (Nan) Adenophorae Radix Tian Dong Asparigi Radix Mai Dong Ophiopogonis Radix Shi Hu Dendrobii Herba Han Lian Cao Ecliptae Herba Gui Ban (Zhi) Carapax et Plastrum Testudinis Bie Jia (Zhi) Plastrum Testudinis Xian He Cao Agrimoniae Herba Zi Zhu Cao Callicar pa Pedunculata Xiao Ji Cephalanoploris Herba Ce Bai Ye Cacumen Biota Huai Hua Sophorae Flos Di Yu Sanguisorbae Radix Qian Cao Rubia
  • the urinary system improvement herbs include but are not limited to the following: Chinese Pin Yin Latin Jin Qian Cao Glechoma Herba Bei Xie Dioscoreae Hypoglauca Rhizoma Hai Jin Sha Lygodii Spora Mu Li (Duan) Ostreae Testa Pu Gong Ying Taraxaci Herba Zhu Ye Lopatheri Herba Shi Gao Gypsum Fibrosum Jin Yin Hua Lonicerae Flos Lian Qiao Forsythiae Fructus Zi Hua Di Ding Violae Herba Yu Xing Cao Houttuyniae Herba Bai Jiang Cao Thlaspi Herba Tu Fu Ling Smilacis Glabrae Rhizoma Ma Chi Xian Portulacae Herba Lu Dou Phaseolus Radiatus Qi Ye Yi Zhi Hua Phizoma Paridis Bai Hua She She cao Hedyotis Diffasae Herb
  • the liver and kidney system improvement herbs include but are not limited to the following: Chinese Pin Yin Latin Niu Xi (Huai) Achyranthis Radix Ba Ji Tian Morindae Radix Shou Di Huang Rehmanniae Radix Wu Wei Zi Schizandrae Fructus Shan Zhu Yu Comi Fructus Qian Shi Euryalis Semen Sang Piao Xiao Mantidis Otheca Sang Ji Sheng Loranthi Ramulus Bie Jia Plastrum Testudinis Nu Zhen Zi Ligustri Lucidi Fructus Gou Qi Zi Lycii Fructus Gui Yuan Euphoria Longan Sang Shen Zi Mori Fructus E Jiao Asini Gelatinum Bai Shao Paeoniae Alba Radix Dang Gui Angelicae Radix He Shou Wu Polygoni Multiflori Radix Du Zhong Eucommiae Cortex Jin Gou Ji Cibotii Rhizoma Xu Duan Dips
  • the effect of administering the composition embodied as described in this specification may be enhanced by additional measures.
  • the patient abstains from eating almost all cold drinks and all cold foods (i.e. drinks and food below room temperature) during the administration period.
  • the administration period is during the administration of the composition.
  • the patient alters his/her lifestyle to consume less or no cold drinks or food even after the administration period.
  • the patient reduces the consumption of spices (including but not limited to peppers and garlic) to a minimum, preferably eliminating spices from his diet, for the administration period.
  • a limited consumption of spices may be acceptable during the administration period. Frequent consumption of spices may offset the effectiveness of certain herbs in the composition.
  • the patient alters his/her lifestyle to consume less or no spices even after the administration period
  • the patient reduces the consumption of raw foods to a minimum for the administration period.
  • Raw food includes but is not limited to raw vegetables, raw fish, raw meat, and raw fruits).
  • the patient alters his/her lifestyle to consume less or no raw food even after the administration period
  • the patient reduces the frequency of sexual intercourse, preferably eliminating intercourse, for the administration period.
  • Frequent sexual stimulation may inflate the prostate.
  • the patient reduces emotional stress, attempting to keep emotional stress to a minimum for the administration period. Emotional disturbances may cause various health related problems leading to reduced viability of the treatment.
  • the patient substantially abstains from consumption of cold drinks, cold food, spices, and raw food, reduces the frequency of sexual intercourse and reduces emotional stress during the administration period.
  • the effective rate of this study was about 100%.

Abstract

The present invention includes compositions and methods of treating and preventing prostate and urinary problems in human males. Additionally, methods of digestive system improvement, blood circulation system improvement, liver and kidney system improvement and urinary system improvement are included.

Description

    FIELD OF THE INVENTION
  • The present invention relates to improvements in animal health, especially the health of humans, particularly male humans. The medical systems of an animal, especially the digestive system, blood circulation system, urinary system, and liver and kidney system, and overall health may be improved by the present invention. [0001]
    • BACKGROUND OF THE INVENTION
  • The prostate is a male reproductive gland, which is located below the bladder and adjacent to the rectum. A normal sized prostate gland is about the size of a walnut and encircles at least part of the urethra (which is the tube used to empty the bladder of urine). Fluid is produced by the prostate gland which then becomes part of the semen. [0002]
  • With age, the prostate gland may enlarge and ultimately block the urethra or bladder. This blockage can cause pain and difficulty in urination and sexual activity may be effected. While not malignant, this condition is called benign hyperplasia (hereinafter “BPH”), and may need to be corrected with surgery. Additionally, many of the symptoms of BPH are also symptoms of prostate cancer. [0003]
  • Prostate cancer is a disease manifested in malignant (cancerous) cells in the prostate tissues. This disease is found mainly in older men. Symptoms include, but are not limited to, weak flow of urine, interrupted flow of urine, frequent urination (especially at night), difficulty urinating, pain or burning during urination, blood in urine, blood in semen, pain in the back, hips or pelvis, and painful ejaculation. [0004]
  • There are several tests for detecting prostate cancer including but not limited to digital rectal examination, PSA test (a lab test that measures the prostate-specific antigen (hereinafter “PSA”) levels in a blood sample), transrectal ultrasound, and biopsy. [0005]
  • PSA is a substance produced by the prostate gland and is often found in increased amount in the blood of prostate cancer victims. Other reasons for elevated PSA levels include infection of the prostate, inflammation of the prostate, or BPH. [0006]
  • PSA levels of less than about 2 ng/ml are associated with a very low risk of cancer. PSA levels from about 4 to about 10 ng/ml are borderline. It is estimated that about 20% to about 30% of men with PSA levels in this range have prostate cancer. About 40% to about 60% of men with PSA levels greater than about 10 ng/ml, are estimated to have prostate cancer. Healthcare professionals usually follow up the PSA test with transrectal ultrasounds and/or biopsies. [0007]
  • Traditional Chinese Medicine (hereinafter “TCM”) does not usually address prostate cancer. See, e.g., Department of TCM Formulas, Beijing TCM University, ed. 195; Tang Tou Ge Jue Bai Hua Jie (Modem Chinese Version of Ancient TCM Formulas), p. 109-121, and 166-176 (Beijing, PRC); People's Hygienic Press; [0008]
  • Shanghai TCM University ed. 1998; Fang Ji Xue (TCM Formulas), p. 98-107 (Hong Kong); Commercial Press; Lu, Henry C., 195 Chinese Natural Cure, p. 245-271 (Toronto); Black Dog & Leventhal Publishers; and Wang, Jinhong ed., Effective TCM Formulas for Neurological and Endocrinological Diseases, p. 237-240, and 280-295 (Jiangsu, PRC). [0009]
  • Other forms of medicine, other than TCM, utilize PSA levels to gauge levels of cancerous activity. TCM is only now beginning to examine liver and kidney system (including, but not limited to kidney, liver and gallbladder) and urinary system (including but not limited to urinary and reproductive organs) problems. These problems may be assessed through, but are not limited to, checking acupuncture points, pulse readings and physical examination of the tongue. Additionally, physical symptoms include but are not limited to swollen prostate and pain or burning during urination. [0010]
  • Conventional (non-TCM) prostate cancer treatments have undesirable side effects. These include but are not limited to incontinence and erectile dysfunction. Combining these side effects with the uncertain impact of treatment on the chance for survival, heightens the need for other treatment and prevention methods. [0011]
  • Prostate and urinary related problems such as, but not limited to, swollen or enlarged prostate, high PSA, pain and/or burning sensations during urination and prostate cancer may be prevented and/or treated by the present invention. [0012]
    • SUMMARY OF THE INVENTION
  • The present invention may be used to treat and/or prevent prostate and urinary problems in animals, preferably human, most preferably human males, including but not limited to prostate cancer, especially the early stages of prostate cancer. [0013]
  • A composition comprising one or more digestive system improvement herbs, one or more blood circulation improvement (including but not limited to maintaining about normal blood temperature, or maintaining about normal and about constant blood flow) herbs, one or more urinary system improvement herbs, one or more liver and kidney system improvement herbs, or combinations thereof is one embodiment of the invention. Herbs are defined to include, but are not limited to, herbs, herbal extracts, any part of an herb, chemicals, chemical extracts, medicine and medicinal substances. [0014]
  • Additionally, an embodiment of the invention is a method of preventing and/or treating prostate problems (including but not limited to, enlarged prostate, prostate cancer, and elevated (benign, precancerous or malignant) levels of PSA, pain during urination, and burning during urination) by administering a composition comprising one or more digestive system improvement herbs, one or more blood circulation improvement herbs, one or more urinary system improvement herbs, one or more liver and kidney system improvement herbs, or combinations thereof. [0015]
  • The digestive system performs the functions of digesting foods, absorbing nutrients, delivering nutrients and fluid to the rest of the body, and helps to make blood. Without being limited or held to the mechanisms, it is believed that the normal functioning of digestive system provides a foundation for a healthy body and a strong immune system. [0016]
  • Another embodiment of the invention is a method of improving performance of the digestive system of an animal by administering a composition comprising astragali seu hedysari radix, codonopsis pilosulae radix, atractylodes rhizoma, poria cocos, raphni semen, xingiberis siccatun rhizoma, atractylodis lanceae rhizoma, amomi fructus, agastache rugosa herba, artemisiae capillaris herba, coicis semen, dianthi herba, evodiae fructus, alpiniae officinarum rhizoma, foeniculi fructus, saussureae radix, cyperi rhizoma, crataegi fructus, massa medicata fermentata, endothelium corneum gigeriae galli, hordei germinatus fructus, oryzae fructus, dioscorea batais rhizoma, dolichoris semen, zizyphi fructus, glycyrrhizae radix, polygonati rhizoma, hominis placenta, reticulatae pericarpium citri or combinations thereof. Improvement of the digestive system may increase the efficiency of the immune system of the animal. [0017]
  • Another embodiment of the invention is a method of improving blood circulation of an animal by administering a composition comprising rehmanniae radix, gardeniae fructus, moutan radicis cortex, glehniae radix, adenophorae radix, asparigi radix, ophiopogonis radix, dendrobii herba, ecliptae herba, carapax et plastrum testudinis, plastrum testudinis, agrimoniae herba, callicar pa pedunculata, cephalanoploris herba, cacumen biota, sophorae flos, sanguisorbae radix, rubiae radix, typhae pollen, loti rhizomatis nodus, notoginseng radix, tribuli fructus, haematitum, bupleuri radix, lycii radicis cortex, paeoniae rubra radix, lithospermi radix, baphicacanthis folium, scrophulariae radix, imperatae rhizoma, prunellae spica, salviae miltiorrhziae radix, cnidii rhizoma (ligustici rhizoma), persicae semen, carthami flos, vaccariae semen, sparganii rhizoma, zedoariae rhizoma, gleditsiae spina, paederiae caulis, centranthera cochinchinensis semen, or combinations thereof. [0018]
  • Another embodiment of the invention is a method of maintaining blood temperature of an animal by administering a composition comprising rehmanniae radix, gardeniae fructus, moutan radicis cortex, glehniae radix, adenophorae radix, asparigi radix, ophiopogonis radix, dendrobii herba, ecliptae herba, carapax et plastrum testudinis, plastrum testudinis, agrimoniae herba, callicar pa pedunculata, cephalanoploris herba, cacumen biota, sophorae flos, sanguisorbae radix, rubiae radix, typhae pollen, loti rhizomatis nodus, notoginseng radix, tribuli fructus, haematitum, bupleuri radix, lycii radicis cortex, paeoniae rubra radix, lithospermi radix, baphicacanthis folium, scrophulariae radix, imperatae rhizoma, prunellae spica, salviae miltiorrhziae radix, cnidii rhizoma (ligustici rhizoma), persicae semen, carthami flos, vaccariae semen, sparganii rhizoma, zedoariae rhizoma, gleditsiae spina, paederiae caulis, centranthera cochinchinensis semen, or combinations thereof. [0019]
  • The urinary system includes the bladder and urinary track, and in males, the prostate gland. Another embodiment of the invention is a method of improving the function of the urinary system of an animal by administering a composition comprising one or more of the group consisting of gelchoma herba, dioscoreae hypoglauca rhizoma, lygodii spora, ostreae testa, taraxaci herba, lopatheri herba, gypsum fibrosum, lonicerae flos, frosythiae fructus, violae herba, houttuyniae herba, thlaspi herba, smilacis glabrae rhizoma, portulacae herba, phaseolus radiatus, phizoma paridis, hedyotis diffasae herba, phellodendri cortex, gentianae radix, sophorae radix, scutellariae radix, polyprous, alismatis rhizoma, plantaginis herba, plantaginis semen, tetrapanax papyriferus, phaseolus calcaratus roxb, mydis stigma, gryllulus chinensis weber, kochiae fructus, polygoni avicularis herba, pyrrosiae folium, talcum and kaolinum, succinum, lumbricus, manitis squama, pinellia rhizoma, pumex, concha arcae, cyclina senensis, or combinations thereof. [0020]
  • The liver and kidney system performs the functions of blood storage and blood purification, blood supply regulation, partially regulates blood circulation, regulates the functions of the urinary system, may promote body growth, consolidates the quality of bone and partially regulates the discharge of body fluid. [0021]
  • Another embodiment of the invention is a method of improving liver and kidney system of an animal by administering a composition comprising one or more of the group consisting of achyranthis radix, morindae radix, rehmanniae radix, schizandrae fructus, comi fructus, euryalis semen, mantidis otheca, loranthi ramulus, plastrum testudinis, ligustri lucidi fructus, lycii fructus, euphora longan, mori fructus, asini gelatinum, paeoniae alba radix, angelicae radix, polygoni multiflori radix, eucommiae cortex, cibotii rhizoma, dipsaci radix, cnidii monnieri fructus, cordyceps senesis, gekko gecko, cuscutae semen, cistanchis herba, alpinia oxyphyllae fructus, epimedii herba, cervus nippon, C. elaphus, cervi degelatinatum cornu, uncariae ramulus cum uncis, immaturi pericarpium citri, sarcodactyli fructus citri, litchi chinensis semen, aurantii semen, cinnamomi cortex, homalomenae rhizoma, acanthopanacis cortex, luffae fasciculus vascularis, or combinations thereof. [0022]
    • DETAILED DESCRIPTION OF SEVERAL EMBODIMENTS
  • Unlike conventional treatments and preventative measures for prostate and urinary problems, without being limited or held to the mechanism, the present invention utilizes herbs to improve the function of the digestive system. This improvement of the digestive system may enhance the immune system and bolster the natural defense of the animal body, preferably the human body, more preferably the male human body. Without being limited or held to mechanisms, this natural defense appears to be crucial in terms of treating many disorders and diseases, including but not limited to prostate cancer, prostate problems, urinary problems, immune system problems, cardiovascular problems, pulmonary problems, reproductive problems, neurological problems, endocrine and metabolic problems, gastrointestinal problems, hepatic and biliary problems, musculaskeleta and connective tissue problems, dermatological problems, and hematological and oncological problems. [0023]
  • The immune system includes the natural defense system of the animal, which wards off disease, infections, viruses, and other illnesses and disorders. [0024]
  • Additionally, without being limited or held to the mechanism, the present invention improves blood circulation, which may help keep blood temperature about normal. Stable, normal blood temperature for an animal may help reduce infection of the prostate and improve the urination function (including but not limited to by regular frequency of urination, eliminating pain and burning during urination, and normalizing flow of urine). Stable, normal blood temperature for an animal may help reduce infection of various organs, including but not limited to the liver, kidneys, and immune system. [0025]
  • The present invention has many embodiments, including but not limited to, mixing the herbs and boiling the mixture to yield a tea, pulverizing the herbs to a powder (preferably a fine powder) and mixing it with water for ingestion, abstracting herbal extracts using chemical solvents which are conventionally known, and preferably pulverizing herbs, encapsulating them and ingesting the capsules orally. [0026]
  • The dosage for an animal may vary according to its health and condition. An average dose is about 20 to about 90 grams, preferably about 20 to about 23 grams or about 80 to about 90 grams, most preferably about 40 to about 45 grams of the mixture. This dose is preferably taken about one to about three times a day, preferably about two to about three times a day. The dose is taken for preferably about 180 to about 730 days. [0027]
  • The digestive system improvement herbs include but are not limited to the following: [0028]
    Chinese Pin Yin
    (Chinese Name) Latin
    Huang Qi (Sheng) Astraali seu Hedysari Radix
    Dang Shen Codonopsis Pilosulae Radix
    Bai Zhu Atractylodes Rhizoma
    Fu Ling Poria Cocos
    Lai Fu Zi Raphni Semen
    Gan Jiang Zingiberis Siccatun Rhizoma
    Cang Zhu Atractylodis Lanceae Rhizoma
    Sha Ren Amomi Fructus
    Huo Xiang Agastache Rugosa Herba
    Yin Chen Artemisiae Capillaris Herba
    Yi Ren Coicis Semen
    Qu Mai Dianthi Herba
    Wu Zhu Yu Evodiae Fructus
    Gao Liang Jiang Alpiniae Officinarum Rhizoma
    Xiao Hui Xiang Foeniculi Fructus
    Mu Xiang Saussureae Radix
    Xiang Fu Cyperi Rhizoma
    Shan Zha Crataegi Fructus
    Shen Qu Massa Medicata Fermentata
    Ji Nei Jin Endothelium Corneum Gigeriae Galli
    Mai Ya Hordei Germinatus Fructus
    Gu Ya Oryzae Fructus
    Shan Yao (Huai) Dioscorea Batatis Rhizoma
    Bai Bian Dou Dolichoris Semen
    Da Zao Zizyphi Fructus
    Gan Cao Glycyrrhizae Radix
    Ren Shen Ginseng Radix
    Huang Jing Polygonati Rhizoma
    Zi He Che Hominis Placenta
    Chen Pi Reticulatae Pericarpium Citri
  • The blood circulation improvement herbs include but are not limited to the following: [0029]
    Chinese Pin Yin Latin
    Sheng Di Huang Rehmanniae Radix
    Zhi Zi Gardeniae Fructus
    Mu Dan Pi Moutan Radicis Cortex
    Sha Shen (Bei) Glehniae Radix
    Sha Shen (Nan) Adenophorae Radix
    Tian Dong Asparigi Radix
    Mai Dong Ophiopogonis Radix
    Shi Hu Dendrobii Herba
    Han Lian Cao Ecliptae Herba
    Gui Ban (Zhi) Carapax et Plastrum Testudinis
    Bie Jia (Zhi) Plastrum Testudinis
    Xian He Cao Agrimoniae Herba
    Zi Zhu Cao Callicar pa Pedunculata
    Xiao Ji Cephalanoploris Herba
    Ce Bai Ye Cacumen Biota
    Huai Hua Sophorae Flos
    Di Yu Sanguisorbae Radix
    Qian Cao Rubiae Radix
    Pu Huang Typhae Pollen
    Ou Jie Loti Rhizomatis Nodus
    San Qi Notoginseng Radix
    Bai Ji Li Tribuli Fructus
    Dai Zhe Shi Haematitum
    Chai Hu Bupleuri Radix
    Di Gu Pi Lycii Radicis Cortex
    Chi Shao Paeoniae Rubra Radix
    Zi Cao Lithospermi Radix
    Da Qing Ye Baphicacanthis Folium
    Xuan Shen Scrophulariae Radix
    Mao Gen Imperatae Rhizoma
    Xia Ku Cao Prunellae Spica
    Dan Shen Salviae Miltiorrhziae Radix
    Chuan Xiong Cnidii Rhizoma (Ligustici Rhizoma)
    Tao Ren Persicae Semen
    Hong Hua Carthami Flos
    Wang Bu Liu Xing Vaccariae Semen
    San Leng Sparganii Rhizoma
    E Zhu Zedoariae Rhizoma
    Zao Jiao Ci Gleditsiae Spina
    Ji Xie Teng Paederiae Caulis
    Hu Ma Ren Centranthera Cochinchinensis Semen
  • The urinary system improvement herbs include but are not limited to the following: [0030]
    Chinese Pin Yin Latin
    Jin Qian Cao Glechoma Herba
    Bei Xie Dioscoreae Hypoglauca Rhizoma
    Hai Jin Sha Lygodii Spora
    Mu Li (Duan) Ostreae Testa
    Pu Gong Ying Taraxaci Herba
    Zhu Ye Lopatheri Herba
    Shi Gao Gypsum Fibrosum
    Jin Yin Hua Lonicerae Flos
    Lian Qiao Forsythiae Fructus
    Zi Hua Di Ding Violae Herba
    Yu Xing Cao Houttuyniae Herba
    Bai Jiang Cao Thlaspi Herba
    Tu Fu Ling Smilacis Glabrae Rhizoma
    Ma Chi Xian Portulacae Herba
    Lu Dou Phaseolus Radiatus
    Qi Ye Yi Zhi Hua Phizoma Paridis
    Bai Hua She She cao Hedyotis Diffasae Herba
    Huang Bai Phellodendri Cortex
    Long Dan Cao Gentianae Radix
    Ku Shen Sophorae Radix
    Huang On Scutellariae Radix
    Zhu Ling Polyporus
    Ze Xie Alismatis Rhizoma
    Che Qian Cao Plantaginis Herba
    Che Qian Zi Plantaginis Semen
    Tong Cao Tetrapanax Papyriferus
    Chi Xiao Dou Phaseolus Calcaratus Roxb
    Yu Mi Xu Maydis Stigma
    Xi Shuai Gryllulus Chinensis Weber
    Di Fu Zi Kochiae Fructus
    Bian Xu Polygoni Avicularis Herba
    Shi Wei Pyrrosiae Folium
    Hua Shi Talcum and Kaolinum
    Hu Po Succinum
    Di Long Lumbricus
    Chuan Shan Jia Manitis Squama
    Ban Xia (Fa) Pinellia Rhizoma
    Nan Xing (Zhi) Arisaematis Rhizoma
    Hai Fu Shi Pumex
    Wa Leng Zi (Duan) Concha Arcae
    Hai Ge Ke Cyclina Senensis
  • The liver and kidney system improvement herbs include but are not limited to the following: [0031]
    Chinese Pin Yin Latin
    Niu Xi (Huai) Achyranthis Radix
    Ba Ji Tian Morindae Radix
    Shou Di Huang Rehmanniae Radix
    Wu Wei Zi Schizandrae Fructus
    Shan Zhu Yu Comi Fructus
    Qian Shi Euryalis Semen
    Sang Piao Xiao Mantidis Otheca
    Sang Ji Sheng Loranthi Ramulus
    Bie Jia Plastrum Testudinis
    Nu Zhen Zi Ligustri Lucidi Fructus
    Gou Qi Zi Lycii Fructus
    Gui Yuan Euphoria Longan
    Sang Shen Zi Mori Fructus
    E Jiao Asini Gelatinum
    Bai Shao Paeoniae Alba Radix
    Dang Gui Angelicae Radix
    He Shou Wu Polygoni Multiflori Radix
    Du Zhong Eucommiae Cortex
    Jin Gou Ji Cibotii Rhizoma
    Xu Duan Dipsaci Radix
    She Chuang Zi Cnidii Monnieri Fructus
    Chong Cao Cordyceps Senensis
    Ge Jie Gekko Gecko
    Tu Si Zi Cuscutae Semen
    Rou Cong Rong Cistanchis Herba
    Yi Zhi Ren Alpinia Oxyphyllae Fructus
    Yin Yang Huo Epimedii Herba
    Lu Rong Cervus Nippon, C. Elaphus
    Lu Jiao Shuang Cervi Degelatinatum Cornu
    Gou Teng Uncariae Ramulus Cum Uncis
    Qing Pi Immaturi Pericarpium Citri
    Fuo Shou Sarcodactyli Fructus Citri
    Li Zhi He Litchi Chinensis Semen
    Ju He Aurantii Semen
    Rou Gui Cinnamomi Cortex
    Qian Nian Jian Homalomenae Rhizoma
    Wu Jia Pi Acanthopanacis Cortex
    Si Gua Luo Luffae Fasciculus Vascularis
  • Further, the effect of administering the composition embodied as described in this specification may be enhanced by additional measures. In one embodiment, the patient abstains from eating almost all cold drinks and all cold foods (i.e. drinks and food below room temperature) during the administration period. The administration period is during the administration of the composition. Preferably, the patient alters his/her lifestyle to consume less or no cold drinks or food even after the administration period. [0032]
  • In another embodiment, the patient reduces the consumption of spices (including but not limited to peppers and garlic) to a minimum, preferably eliminating spices from his diet, for the administration period. A limited consumption of spices may be acceptable during the administration period. Frequent consumption of spices may offset the effectiveness of certain herbs in the composition. Preferably, the patient alters his/her lifestyle to consume less or no spices even after the administration period [0033]
  • In another embodiment, the patient reduces the consumption of raw foods to a minimum for the administration period. Raw food includes but is not limited to raw vegetables, raw fish, raw meat, and raw fruits). Preferably, the patient alters his/her lifestyle to consume less or no raw food even after the administration period [0034]
  • In another embodiment, the patient reduces the frequency of sexual intercourse, preferably eliminating intercourse, for the administration period. Frequent sexual stimulation may inflate the prostate. [0035]
  • In another embodiment, the patient reduces emotional stress, attempting to keep emotional stress to a minimum for the administration period. Emotional disturbances may cause various health related problems leading to reduced viability of the treatment. [0036]
  • In another embodiment, the patient substantially abstains from consumption of cold drinks, cold food, spices, and raw food, reduces the frequency of sexual intercourse and reduces emotional stress during the administration period.[0037]
    • EXAMPLE 1
  • The following ingredients were combined in a capsule. The about 40 to about 45 grams capsules were taken two to three times a day for about 180 to about 730 days with no side effects. [0038]
  • The effective rate of this study was about 100%. Two of the patients tested for prostate cancer by biopsy before treatment by the following capsule. After treatment, these patients had no prostate cancer as determined by a biopsy. All of the patients had normal PSA after an administration period with no side-effects reported. [0039]
  • All percentages given in this application are weight percentages, unless otherwise specified. [0040]
    Chinese Name Percentage
    (Pin Yin) Latin (by weight)
    Huang Qi (Sheng) Astragali seu Hedysari Radix 5.7
    Dang Shen Codonopsis Pilosulae Radix 5.7
    Bai Zhu Atractylodes Rhizoma 8.5
    Fu Ling Pona Cocos 11.4 
    Lai Fu Zi Raphni Semen 5.2
    Gan Jiang Zingiberis Siccatum Rhizoma 5.7
    Sheng Di Huang Rehmanniae Radix 5.7
    Zhi Zi Gardeniae Fructus 5.7
    Mu Dan Pi Moutan Radicis Cortx 5.7
    Jin Qian Cao Glechoma Herba 5.7
    Bei Xie Dioscoreae Hypoglauca Rhizoma 5.7
    Hai Jin Sha Lygodii Spora 3.7
    Mu Li (Duan) Ostreae Testa 5.7
    Niu Xi (Huai) Achyranthis Radix 5.7
    Ba Ji Tian Morin dae Radix 5.7
    Shou Di Huang Rehmanniae Radix 8.5
  • It is to be understood that while the invention has been described in conjunction with the detailed description thereof, that the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are evident from a review of the following claims. What is claimed is:[0041]

Claims (28)

1. A composition comprising one or more digestive system improvement herbs, one or more blood circulation improvement herbs, one or more urinary system improvement herbs, and one or more liver and kidney system improvement herbs.
2. The composition of claim 1 wherein the digestive system improvement herbs comprise one or more of the group consisting of astragali seu hedysari radix, codonopsis pilosulae radix, atractylodes rhizoma, poria cocos, raphni semen, zingiberis siccatun rhizoma, atractylodis lanceae rhizoma, amomi fructus, agastache rugosa herba, artemisiae capillaris herba, coicis semen, dianthi herba, evodiae fructus, alpiniae officinarum rhizoma, foeniculi fructus, saussureae radix, cyperi rhizoma, crataegi fructus, massa medicata fermentata, endothelium corneum gigeriae galli, hordei germinatus fructus, oryzae fructus, dioscorea batais rhizoma, dolichoris semen, zizyphi fructus, glycyrrhizae radix, polygonati rhizoma, hominis placenta, and reticulatae pericarpium citri.
3. The composition of claim 1 wherein the blood circulation improvement herbs comprise one or more of the group consisting of rehmanniae radix, gardeniae fructus, moutan radicis cortex, glehniae radix, adenophorae radix, asparigi radix, ophiopogonis radix, dendrobii herba, ecliptae herba, carapax et plastrum testudinis, plastrum testudinis, agrimoniae herba, callicar pa pedunculata, cephalanoploris herba, cacumen biota, sophorae flos, sanguisorbae radix, rubiae radix, typhae pollen, loti rhizomatis nodus, notoginseng radix, tribuli fructus, haematitum, bupleuri radix, lycii radicis cortex, paeoniae rubra radix, lithospermi radix, baphicacanthis folium, scrophulariae radix, imperatae rhizoma, prunellae spica, salviae miltiorrhziae radix, cnidii rhizoma (ligustici rhizoma), persicae semen, carthami flos, vaccariae semen, sparganii rhizoma, zedoariae rhizoma, gleditsiae spina, paederiae caulis and centranthera cochinchinensis semen.
4. The composition of claim 1 wherein the urinary system improvement herbs comprise one or more of the group consisting of gelchoma herba, dioscoreae hypoglauca rhizoma, lygodii spora, ostreae testa, taraxaci herba, lopatheri herba, gypsum fibrosum, lonicerae flos, frosythiae fructus, violae herba, houttuyniae herba, thlaspi herba, smilacis glabrae rhizoma, portulacae herba, phaseolus radiatus, phizoma paridis, hedyotis diffasae herba, phellodendri cortex, gentianae radix, sophorae radix, scutellariae radix, polyprous, alismatis rhizoma, plantaginis herba, plantaginis semen, tetrapanax papyriferus, phaseolus calcaratus roxb, mydis stigma, gryllulus chinensis weber, kochiae fructus, polygoni avicularis herba, pyrrosiae folium, talcum and kaolinum, succinum, lumbricus, manitis squama, pinellia rhizoma, pumex, concha arcae and cyclina senensis.
5. The composition of claim 1 wherein the liver and kidney system improvement herbs comprise one or more of the group consisting of achyranthis radix, morindae radix, rehmanniae radix, schizandrae fructus, comi fructus, euryalis semen, mantidis otheca, loranthi ramulus, plastrum testudinis, ligustri lucidi fructus, lycii fructus, euphora longan, mori fructus, asini gelatinum, paeoniae alba radix, angelicae radix, polygoni multiflori radix, eucommiae cortx, cibotii rhizoma, dipsaci radix, cnidii monnieri fructus, cordyceps senesis, gekko gecko, cuscutae semen, cistanchis herba, alpinia oxyphyllae fructus, epimedii herba, cervus nippon, C. elaphus, cervi degelatinatum cornu, uncariae ramulus cum uncis, immaturi pericarpium citri, sarcodactyli fructus citri, litchi chinensis semen, aurantii semen, cinnamomi cortex, homalomenae rhizoma, acanthopanacis cortex and luffae fasciculus vascularis.
6. The composition of claim 1 wherein the composition is prepared as a tea.
7. The composition of claim 1 wherein the composition is a capsule.
8. The composition of claim 1 wherein the composition is a powder.
9. The composition of claim 1 wherein the composition is an extract obtained by using a chemical solvent.
10. A composition comprising astragali seu hedysari radix, codonopsis pilosulae radix, atractylodes rhizoma, poria cocos, raphni semen, xingiberis siccatun rhizoma, rehmanniae radix, gardeniae fructus, moutan radicis cortex, gelchoma herba, dioscoreae hypoglauca rhizoma, lygodii spora, ostreae testa, achyranthis radix, morindae radix, and rehmanniae radix.
11. The composition of claim 10 wherein the percentages of the total composition are:
5.7% astragali seu hedysari radix,
5.7% codonopsis pilosulae radix,
8.5% atractylodes rhizoma,
11.4% poria cocos,
5.2% raphni semen,
5.7% xingiberis siccatun rhizoma,
5.7% rehmanniae radix,
5.7% gardeniae fructus,
5.7% moutan radicis cortex,
5.7% gelchoma herba,
5.7% dioscoreae hypoglauca rhizoma,
3.7% lygodii spora,
5.7% ostreae testa,
5.7% achyranthis radix,
5.7% morindae radix, and
8.5% rehmanniae radix.
12. A method of preventing and/or treating prostate and urinary problems comprising administering a composition comprising one or more digestive system improvement herbs, one or more blood circulation improvement herbs, one or more urinary system improvement herbs, and one or more liver and kidney system improvement herbs.
13. The method of claim 12 wherein the composition has a dose of about 20 grams to about 90 grams.
14. The method of claim 12 wherein the composition has a dose of about 40 to about 45 grams.
15. The method of claim 12 wherein the administering occurs about two to about three times a day for about 180 to about 730 days.
16. The method of claim 12 further comprising substantially abstaining from consumption of cold drinks and cold foods during the administering of the composition.
17. The method of claim 12 further comprising substantially abstaining from consumption of spices during the administering of the composition.
18. The method of claim 12 further comprising substantially abstaining from consumption of raw food during the administering of the composition.
19. The method of claim 12 further comprising substantially reducing frequency of sexual intercourse during the administering of the composition.
20. The method of claim 12 further comprising substantially reducing emotional stress during the administering of the composition.
21. The method of claim 12 wherein the composition comprises astragali seu hedysari radix, codonopsis pilosulac radix, atractylodes rhizoma, poria cocos, raphni semen, xingiberis siccatun rhizoma, rehmanniae radix, gardeniae fructus, moutan radicis cortex, gelchoma herba, dioscoreae hypoglauca rhizoma, lygodii spora, ostreae testa, achyranthis radix, morindae radix, and rehmanniae radix.
22. The method of claim 12 wherein the prostrate and urinary problems comprise one or more of the group consisting of enlarged prostate, elevated prostate-specific antigen (“PSA”) levels, pain during urination, burning during urination and prostate cancer.
23. A method of improving performance of a digestive system of an animal comprising administering a composition comprising one or more of the group consisting of astragali seu hedysari radix, codonopsis pilosulae radix, atractylodes rhizoma, poria cocos, raphni semen, xingiberis siccatun rhizoma, atractylodis lanceae rhizoma, amomi fructus, agastache rugosa herba, artemisiae capillaris herba, coicis semen, dianthi herba, evodiae fructus, alpiniae officinarum rhizoma, foeniculi fructus, saussureae radix, cyperi rhizoma, crataegi fructus, massa medicata fermentata, endothelium corneum gigeriae galli, hordei germinatus fructus, oryzae fructus, dioscorea batais rhizoma, dolichoris semen, zizyphi fructus, glycyrrhizae radix, polygonati rhizoma, hominis placenta, and reticulatae pericarpium citri.
24. A method of improving immune system of an animal comprising administering a composition comprising one or more of the group consisting of astragali seu hedysari radix, codonopsis pilosulae radix, atractylodes rhizoma, poria cocos, raphni semen, xingiberis siccatun rhizoma, atractylodis lanceae rhizoma, amomi fructus, agastache rugosa herba, artemisiae capillaris herba, coicis semen, dianthi herba, evodiae fructus, alpiniae officinarum rhizoma, foeniculi fructus, saussureae radix, cyperi rhizoma, crataegi fructus, massa medicata fermentata, endothelium corneum gigeriae galli, hordei germinatus fructus, oryzae fructus, dioscorea batais rhizoma, dolichoris semen, zizyphi fructus, glycyrrhizae radix, polygonati rhizoma, hominis placenta, and reticulatae pericarpium citri.
25. A method of improving blood circulation of an animal comprising administering a composition comprising one or more of the group consisting of rehmanniae radix, gardeniae fructus, moutan radicis cortex, glehniae radix, adenophorae radix, asparigi radix, ophiopogonis radix, dendrobii herba, ecliptae herba, carapax et plastrum testudinis, plastrum testudinis, agrimoniae herba, callicar pa pedunculata, cephalanoploris herba, cacumen biota, sophorae flos, sanguisorbae radix, rubiae radix, typhae pollen, loti rhizomatis nodus, notoginseng radix, tribuli fructus, haematitum, bupleuri radix, lycii radicis cortex, paeoniae rubra radix, lithospermi radix, baphicacanthis folium, scrophulariae radix, imperatae rhizoma, prunellae spica, salviae miltiorrhziae radix, cnidii rhizoma (ligustici rhizoma), persicae semen, carthami flos, vaccariae semen, sparganii rhizoma, zedoariae rhizoma, gleditsiae spina, paederiae caulis and centranthera cochinchinensis semen.
26. A method of maintaining a blood temperature of an animal comprising administering a composition comprising one or more of the group consisting of rehmanniae radix, gardeniae fructus, moutan radicis cortex, glehniae radix, adenophorae radix, asparigi radix, ophiopogonis radix, dendrobii herba, ecliptae herba, carapax et plastrum testudinis, plastrum testudinis, agrimoniae herba, callicar pa pedunculata, cephalanoploris herba, cacumen biota, sophorae flos, sanguisorbae radix, rubiae radix, typhae pollen, loti rhizomatis nodus, notoginseng radix, tribuli fructus, haematitum, bupleuri radix, lycii radicis cortex, paeoniae rubra radix, lithospermi radix, baphicacanthis folium, scrophulariae radix, imperatae rhizoma, prunellae spica, salviae miltiorrhziae radix, cnidii rhizoma (ligustici rhizoma), persicae semen, carthami flos, vaccariae semen, sparganii rhizoma, zedoariae rhizoma, gleditsiae spina, paederiae caulis and centranthera cochinchinensis semen.
27. A method of improving a urinary system of an animal comprising administering a composition comprising one or more of the group consisting of gelchoma herba, dioscoreae hypoglauca rhizoma, lygodii spora, ostreae testa, taraxaci herba, lopatheri herba, gypsum fibrosum, lonicerae flos, frosythiae fructus, violae herba, houttuyniae herba, thlaspi herba, smilacis glabrae rhizoma, portulacae herba, phaseolus radiatus, phizoma paridis, hedyotis diffasae herba, phellodendri cortex, gentianae radix, sophorae radix, scutellariae radix, polyprous, alismatis rhizoma, plantaginis herba, plantaginis semen, tetrapanax papyriferus, phaseolus calcaratus roxb, mydis stigma, gryllulus chinensis weber, kochiae fructus, polygoni avicularis herba, pyrrosiae folium, talcum and kaolinum, succinum, lumbricus, manitis squama, pinellia rhizoma, pumex, concha arcae and cyclina senensis.
28. A method of improving liver and kidney system of an animal comprising administering a composition comprising one or more of the group consisting of achyranthis radix, morindae radix, rehmanniae radix, schizandrae fructus, comi fructus, euryalis semen, mantidis otheca, loranthi ramulus, plastrum testudinis, ligustri lucidi fructus, lycii fructus, euphora longan, mori fructus, asini gelatinum, paeoniae alba radix, angelicae radix, polygoni multiflori radix, eucommiae cortx, cibotii rhizoma, dipsaci radix, cnidii monnieri fructus, cordyceps senesis, gekko gecko, cuscutae semen, cistanchis herba, alpinia oxyphyllae fructus, epimedii herba, cervus nippon, C. elaphus, cervi degelatinatum cornu, uncariae ramulus cum uncis, immaturi pericarpium citri, sarcodactyli fructus citri, litchi chinensis semen, aurantii semen, cinnamomi cortex, homalomenae rhizoma, acanthopanacis cortex and luffae fasciculus vascularis.
US10/307,651 2002-12-02 2002-12-02 Compositions and methods for treating prostate cancer Abandoned US20040105902A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/307,651 US20040105902A1 (en) 2002-12-02 2002-12-02 Compositions and methods for treating prostate cancer
PCT/US2003/038114 WO2004050026A2 (en) 2002-12-02 2003-12-01 Compositions and methods for treating prostate cancer
AU2003293194A AU2003293194A1 (en) 2002-12-02 2003-12-01 Compositions and methods for treating prostate cancer
US11/082,987 US7300676B2 (en) 2002-12-02 2005-03-18 Herbal composition for treatment of digestive and urinary disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/307,651 US20040105902A1 (en) 2002-12-02 2002-12-02 Compositions and methods for treating prostate cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/082,987 Division US7300676B2 (en) 2002-12-02 2005-03-18 Herbal composition for treatment of digestive and urinary disorders

Publications (1)

Publication Number Publication Date
US20040105902A1 true US20040105902A1 (en) 2004-06-03

Family

ID=32392606

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/307,651 Abandoned US20040105902A1 (en) 2002-12-02 2002-12-02 Compositions and methods for treating prostate cancer
US11/082,987 Expired - Lifetime US7300676B2 (en) 2002-12-02 2005-03-18 Herbal composition for treatment of digestive and urinary disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/082,987 Expired - Lifetime US7300676B2 (en) 2002-12-02 2005-03-18 Herbal composition for treatment of digestive and urinary disorders

Country Status (3)

Country Link
US (2) US20040105902A1 (en)
AU (1) AU2003293194A1 (en)
WO (1) WO2004050026A2 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265402A1 (en) * 2003-06-30 2004-12-30 Industrial Technology Research Institute Pharmaceutical composition and method for making the same
US20050147699A1 (en) * 2003-12-31 2005-07-07 Rey-Yuh Wu Astragalus radix and codonopsis pilosulae radix mixed extract for inhibiting carcinogenesis and metastasis
US20060068033A1 (en) * 2004-09-30 2006-03-30 Lee Ai J Alternative remedy-based composition for enhancing fertility
US20060216366A1 (en) * 2005-03-23 2006-09-28 Karl Tsim Wah K Herbal compositions useful in cancer treatment
US20060275510A1 (en) * 2005-06-03 2006-12-07 Hong Kong Jockey Club Institute Of Chinese Medicine Limited Formulations for menopausal syndromes
US20070059386A1 (en) * 2005-09-12 2007-03-15 Tsun-Nin Lee Modular system for novel Chinese herbal formulas
US20070275103A1 (en) * 2005-01-20 2007-11-29 Jung-Keun Kim Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis
WO2012108746A2 (en) * 2011-02-11 2012-08-16 주식회사 한국전통의학연구소 Composition and cosmetic composition for treating brain cancer comprising rubia cordifolia root extract
CN102692477A (en) * 2012-06-14 2012-09-26 漳州片仔癀药业股份有限公司 Medicinal composition used for treating fatty liver and quality detection method thereof
WO2012134170A2 (en) * 2011-03-28 2012-10-04 주식회사 한국전통의학연구소 Composition for lung cancer treatment and composition for cosmetics containing rubiae radix extract
CN102716315A (en) * 2012-06-29 2012-10-10 重庆工商大学 Kidney yang tonifying health care medicinal liquor and preparation method thereof
CN102793842A (en) * 2011-05-23 2012-11-28 杨凯善 Health-care medicine
CN103054981A (en) * 2013-01-31 2013-04-24 邵宏敏 External traditional Chinese medicine for treating abdominal malignant tumours
CN103063799A (en) * 2013-01-01 2013-04-24 吉林紫鑫药业股份有限公司 Method for comprehensively detecting active ingredients of Longdan Xiegan particles
CN103134894A (en) * 2011-11-25 2013-06-05 张金荣 Detecting method of traditional Chinese medicine compositions for treating chronic prostatitis
CN103405647A (en) * 2013-08-13 2013-11-27 何昌净 TCM composition for treating nephritis and kidney failure
CN103751351A (en) * 2013-12-06 2014-04-30 济南新起点医药科技有限公司 Preparation method of Qingmei cold-treatment tablet and use of Qingmei cold-treatment tablet in drug for inhibiting Leydig cell tumor cell MLTC-1 proliferation
WO2014077432A1 (en) * 2012-11-16 2014-05-22 주식회사 한국전통의학연구소 Composition containing rubiae radix extract for renal cancer treatment and cosmetics
CN104705187A (en) * 2015-03-19 2015-06-17 马关壮达农业科技有限公司 Centranthera grandiflora tissue culture method
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
CN104833762A (en) * 2015-01-30 2015-08-12 吉林修正药业新药开发有限公司 Quality control method of drug for treating lumbosacral pain
US20160271201A1 (en) * 2015-03-18 2016-09-22 Wei-Ming Chen Herbal composition and method of use
CN107518384A (en) * 2016-06-22 2017-12-29 江西江中食疗科技有限公司 A kind of composition and preparation method thereof
CN110742901A (en) * 2019-11-28 2020-02-04 郑州大学第一附属医院 Metabolism check point FBP1 agonist and application thereof in anti-tumor aspect
CN111693630A (en) * 2020-07-16 2020-09-22 华润三九（郴州）制药有限公司 Construction method and application of hemorrhoid treating tablet HPLC standard fingerprint

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100634910B1 (en) * 2002-06-05 2006-10-17 신준식 FATIGUE RECOVERY MEDICINE FOR CHANGING IN mRNA LEVELS OF STRESS-RELATED GENES
WO2006006768A1 (en) * 2004-07-14 2006-01-19 Rnl Life Science Ltd. Composition for promoting growth of animal comprising extracts of artemisia capillaris thunberg, acanthopanax and garlic and feed composition for promoting growth comprising the composition
CN102552509B (en) * 2010-12-22 2013-08-28 四川省中医药科学院中医研究所 Traditional Chinese medicine combination for reducing heat and relieving cough
CN102406918A (en) * 2011-11-30 2012-04-11 宋爱民 Traditional Chinese preparation for treating nervous vomiting
US8586106B2 (en) 2011-12-06 2013-11-19 The Concentrate Manufacturing Company Of Ireland Fatigue-relieving herbal extracts and beverages comprising the same
CN103169796A (en) * 2011-12-20 2013-06-26 王佳丽 Medicine for treating agranulocytosis with fungal infection of blood disease patients
CN102526279B (en) * 2012-02-12 2013-08-28 贾奎 Chinese medicinal composition for treating central high fever caused by acute cerebrovascular disease and preparation method for Chinese medicinal composition
CN102526642B (en) * 2012-03-20 2013-12-11 南宁市品迪生物工程有限公司 Method for treating prostatitis comprehensively
CN102697913B (en) * 2012-05-16 2014-02-19 江苏苏南药业实业有限公司 Antitumor drug composition and preparation method thereof
CN102716339B (en) * 2012-06-14 2013-10-23 刘瑞莲 Chinese medicinal composition for treating uremia, and preparation method and application thereof
CN102716419B (en) * 2012-06-18 2013-12-04 河北恒祥医药集团扁鹊制药有限公司 Compound oral liquid for developing intelligence and tonifying kidneys
CN102895387B (en) * 2012-08-28 2014-06-18 吉林金麦通制药有限公司 Kidney-yang-warming medicine composition, and preparation thereof and preparation method thereof
CN102940720A (en) * 2012-11-22 2013-02-27 山东省立医院 Anti-hepatoma traditional Chinese medicine compound preparation
CN103182063A (en) * 2013-01-01 2013-07-03 夏义深 Chinese patented drug pill for treating cancer
CN103223052B (en) * 2013-04-27 2015-05-27 陈晖� Traditional Chinese medicine used for treating prostatitis
CN103230468A (en) * 2013-04-28 2013-08-07 苏州谷力生物科技有限公司 Traditional Chinese medicine composition with functions of tonifying spleens and nourishing stomachs and preparation method thereof
CN103751350B (en) * 2013-12-06 2016-03-02 侯玲 A kind of preparation method of Armeniaca mume Sieb. common cold tablet and the application in suppression leukaemia L1210 cell proliferation thereof
CN103800499A (en) * 2013-12-10 2014-05-21 济南新起点医药科技有限公司 Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting melanoma cell B16 from cell proliferation
CN103655910B (en) * 2013-12-23 2015-07-15 广东众生药业股份有限公司 Application of compound thrombosis capsule inn aspect of liver protection
CN103720827B (en) * 2013-12-25 2016-06-29 柳州市中医院 A kind of Chinese medicine composition treating chronic superficial gastritis and preparation method thereof
CN103816238B (en) * 2014-03-01 2016-02-03 山东大学齐鲁医院 Treat Chinese medicine strumous
CN104187921A (en) * 2014-07-22 2014-12-10 杨青 A beverage assisting weight reduction
CN104225392A (en) * 2014-10-14 2014-12-24 段永胜 Traditional herbal preparation for treating chronic urocystitis and preparation method thereof
CN104667177A (en) * 2015-02-06 2015-06-03 苏州市天灵中药饮片有限公司 Traditional Chinese medicinal tea capable of tonifying spleen and preparation method of tea
KR101716956B1 (en) * 2015-06-08 2017-03-17 김동철 Herbal medicine mixed composition for relaxing and curing of prostate infection and prostatism and manufacturing method thereof
CN105004830B (en) * 2015-07-21 2016-06-08 成都中医药大学 Measure the HPLC-ELSD method of 5 kinds of saponin constituents in Radix Ophiopogonis simultaneously
CN105079675A (en) * 2015-09-16 2015-11-25 周景天 Traditional Chinese medicine for treating tinnitus and preparation method of traditional Chinese medicine
CN105213920B (en) * 2015-10-10 2019-02-22 河南大学 Intelligence development leaf extract prevents, treats the application on liver injury medicament in preparation
CN105250802A (en) * 2015-12-01 2016-01-20 臧海阳 Traditional Chinese medicine composition for treating bladder damp-heat type stranguria
CN105250800A (en) * 2015-12-01 2016-01-20 臧海阳 Traditional Chinese medicine composition for treating damp-heat downward flow type urinary system infection
JP7343192B2 (en) * 2018-06-13 2023-09-12 ベイラー カレッジ オブ メディスン Development of health food supplements and antioxidants to control hyperuricemia and oxidative stress

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225203A (en) * 1987-07-01 1993-07-06 Kim Young S Pharmaceutical liquid composition containing Bezoar bovis
US20020031559A1 (en) * 2000-03-08 2002-03-14 Liang Kin C. Herbal suppositories
US6495174B1 (en) * 2001-02-21 2002-12-17 Sarfaraz K. Niazi Herbal composition for the treatment of alopecia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930012028A (en) * 1991-12-19 1993-07-20 박용성 Herbal Medicine
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5874084A (en) * 1996-07-19 1999-02-23 Yng-Wong; Quing Non Using complex herbal formulations to treat hot flashes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225203A (en) * 1987-07-01 1993-07-06 Kim Young S Pharmaceutical liquid composition containing Bezoar bovis
US5225203C1 (en) * 1987-07-01 2001-05-15 Kim Won Kyq Son Pharmaceutical liquid composition containing bezoar bovis
US20020031559A1 (en) * 2000-03-08 2002-03-14 Liang Kin C. Herbal suppositories
US6495174B1 (en) * 2001-02-21 2002-12-17 Sarfaraz K. Niazi Herbal composition for the treatment of alopecia

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958162B2 (en) * 2003-06-30 2005-10-25 Industrial Technology Research Institute Herbal composition for treating allergic disorders and method for making the same
US20040265402A1 (en) * 2003-06-30 2004-12-30 Industrial Technology Research Institute Pharmaceutical composition and method for making the same
US20050147699A1 (en) * 2003-12-31 2005-07-07 Rey-Yuh Wu Astragalus radix and codonopsis pilosulae radix mixed extract for inhibiting carcinogenesis and metastasis
US20060068033A1 (en) * 2004-09-30 2006-03-30 Lee Ai J Alternative remedy-based composition for enhancing fertility
US7410657B2 (en) * 2004-09-30 2008-08-12 Ai Ja Lee Alternative remedy-based composition for enhancing fertility
US20070275103A1 (en) * 2005-01-20 2007-11-29 Jung-Keun Kim Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis
US7811612B2 (en) * 2005-01-20 2010-10-12 Oscotec Inc. Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis
US7455862B2 (en) * 2005-03-23 2008-11-25 Lee's Pharmaceutical (Hong Kong) Limited Herbal compositions useful in cancer treatment
US20060216366A1 (en) * 2005-03-23 2006-09-28 Karl Tsim Wah K Herbal compositions useful in cancer treatment
US20060275510A1 (en) * 2005-06-03 2006-12-07 Hong Kong Jockey Club Institute Of Chinese Medicine Limited Formulations for menopausal syndromes
US20070059386A1 (en) * 2005-09-12 2007-03-15 Tsun-Nin Lee Modular system for novel Chinese herbal formulas
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
WO2012108746A3 (en) * 2011-02-11 2012-12-20 주식회사 한국전통의학연구소 Composition and cosmetic composition for treating brain cancer comprising rubia cordifolia root extract
WO2012108746A2 (en) * 2011-02-11 2012-08-16 주식회사 한국전통의학연구소 Composition and cosmetic composition for treating brain cancer comprising rubia cordifolia root extract
WO2012134170A2 (en) * 2011-03-28 2012-10-04 주식회사 한국전통의학연구소 Composition for lung cancer treatment and composition for cosmetics containing rubiae radix extract
WO2012134170A3 (en) * 2011-03-28 2013-01-17 주식회사 한국전통의학연구소 Composition for lung cancer treatment and composition for cosmetics containing rubiae radix extract
CN102793842A (en) * 2011-05-23 2012-11-28 杨凯善 Health-care medicine
CN103134894A (en) * 2011-11-25 2013-06-05 张金荣 Detecting method of traditional Chinese medicine compositions for treating chronic prostatitis
CN102692477A (en) * 2012-06-14 2012-09-26 漳州片仔癀药业股份有限公司 Medicinal composition used for treating fatty liver and quality detection method thereof
CN102716315A (en) * 2012-06-29 2012-10-10 重庆工商大学 Kidney yang tonifying health care medicinal liquor and preparation method thereof
WO2014077432A1 (en) * 2012-11-16 2014-05-22 주식회사 한국전통의학연구소 Composition containing rubiae radix extract for renal cancer treatment and cosmetics
CN103063799A (en) * 2013-01-01 2013-04-24 吉林紫鑫药业股份有限公司 Method for comprehensively detecting active ingredients of Longdan Xiegan particles
CN103054981A (en) * 2013-01-31 2013-04-24 邵宏敏 External traditional Chinese medicine for treating abdominal malignant tumours
CN103405647A (en) * 2013-08-13 2013-11-27 何昌净 TCM composition for treating nephritis and kidney failure
CN103751351A (en) * 2013-12-06 2014-04-30 济南新起点医药科技有限公司 Preparation method of Qingmei cold-treatment tablet and use of Qingmei cold-treatment tablet in drug for inhibiting Leydig cell tumor cell MLTC-1 proliferation
CN104833762A (en) * 2015-01-30 2015-08-12 吉林修正药业新药开发有限公司 Quality control method of drug for treating lumbosacral pain
US20160271201A1 (en) * 2015-03-18 2016-09-22 Wei-Ming Chen Herbal composition and method of use
US9861676B2 (en) * 2015-03-18 2018-01-09 Wei-Ming Chen Herbal composition and method of use
CN104705187A (en) * 2015-03-19 2015-06-17 马关壮达农业科技有限公司 Centranthera grandiflora tissue culture method
CN107518384A (en) * 2016-06-22 2017-12-29 江西江中食疗科技有限公司 A kind of composition and preparation method thereof
CN110742901A (en) * 2019-11-28 2020-02-04 郑州大学第一附属医院 Metabolism check point FBP1 agonist and application thereof in anti-tumor aspect
CN111693630A (en) * 2020-07-16 2020-09-22 华润三九（郴州）制药有限公司 Construction method and application of hemorrhoid treating tablet HPLC standard fingerprint

Also Published As

Publication number Publication date
WO2004050026A3 (en) 2004-08-19
AU2003293194A1 (en) 2004-06-23
US20050163870A1 (en) 2005-07-28
US7300676B2 (en) 2007-11-27
AU2003293194A8 (en) 2004-06-23
WO2004050026A2 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
US7300676B2 (en) Herbal composition for treatment of digestive and urinary disorders
US20060141071A1 (en) Compositions and methods for treating gynecological disorders
CN101912585B (en) Medicament for treating myoma of uterus and preparation method thereof
CN103156981A (en) Traditional Chinese medicine composition for treating uterine hypoplasia, and preparation method and application thereof
CN101214315B (en) Medicament for preventing and treating gynaecologic hemorrhage and preparation thereof
CN104043022A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN102302659A (en) Chinese medicinal composition for kidney-yang deficiency and phlegm-retention type polycystic ovanian syndrome
CN104225486A (en) Traditional Chinese medicine for treating chronic cholecystitis
CN102274445A (en) Cassia twig common burreed rhizome tumor eliminating pills
CN102302668B (en) Pharmaceutical composition for treating polycystic ovary syndrome (PCOS)
CN107753880A (en) A kind of pharmaceutical composition for treating dysmenorrhoea and preparation method thereof
CN103169745A (en) Traditional Chinese medicine composition for treating hematuria and application thereof
CN105497262A (en) Medicine composition for treating liver-yin and kidney-yin deficiency type polycystic ovarian syndrome
CN104984020A (en) Traditional Chinese medicinal preparation for treating hysteromyoma, and preparation method thereof
CN104771637A (en) Cholagogic and lithagogue agent for treating gallstone and preparation method thereof
CN104840865A (en) Traditional Chinese medicine preparation for treating gouty arthritis
CN104547489A (en) Use of traditional Chinese medicine composition in preparation of medicine for treating comminuted fracture
CN104189402A (en) Traditional Chinese medicine preparation for treating uterine bleeding
CN106109894A (en) A kind of Chinese medicine composition preventing and treating person in middle and old age's constipation and preparation method thereof
CN105663870A (en) Traditional Chinese medicinal composition for treating hydronephrosis
CN105169111A (en) Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition
CN105168418A (en) Composition for treating polycystic ovarian syndrome and preparation method
CN105435192A (en) External vaginal gel for treating uterine fibroids and production method of external vaginal gel
CN105343425A (en) Traditional Chinese medicine composition for lower abdomen cold pain caused by delay of menstruation and preparing method of traditional Chinese medicine composition
CN105412378A (en) Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION